These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 35450611)

  • 1. Arrhythmogenic Right Ventricular Cardiomyopathy.
    Krahn AD; Wilde AAM; Calkins H; La Gerche A; Cadrin-Tourigny J; Roberts JD; Han HC
    JACC Clin Electrophysiol; 2022 Apr; 8(4):533-553. PubMed ID: 35450611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arrhythmogenic right ventricular cardiomyopathy: diverse substrate characteristics and ablation outcome.
    Cheng WH; Chung FP; Lin YJ; Lo LW; Chang SL; Hu YF; Tuan TC; Chao TF; Liao JN; Lin CY; Chang TY; Kuo L; Wu CI; Liu CM; Liu SH; Chen SA
    Rev Cardiovasc Med; 2021 Dec; 22(4):1295-1309. PubMed ID: 34957771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of patients with Arrhythmogenic Right Ventricular Cardiomyopathy in the Nordic countries.
    Haugaa KH; Bundgaard H; Edvardsen T; Eschen O; Gilljam T; Hansen J; Jensen HK; Platonov PG; Svensson A; Svendsen JH
    Scand Cardiovasc J; 2015; 49(6):299-307. PubMed ID: 26395672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and predictors of sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy: a pooled analysis.
    Agbaedeng TA; Roberts KA; Colley L; Noubiap JJ; Oxborough D
    Europace; 2022 Oct; 24(10):1665-1674. PubMed ID: 35298614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes after catheter ablation of ventricular tachycardia without implantable cardioverter-defibrillator in selected patients with arrhythmogenic right ventricular cardiomyopathy.
    Gandjbakhch E; Laredo M; Berruezo A; Gourraud JB; Sellal JM; Martins R; Sacher F; Pison L; Pruvot E; Jáuregui B; Frontera A; Kumar S; Wong T; DellaBella P; Maury P
    Europace; 2021 Sep; 23(9):1428-1436. PubMed ID: 34427302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy.
    Calkins H; Corrado D; Marcus F
    Circulation; 2017 Nov; 136(21):2068-2082. PubMed ID: 29158215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator.
    Jordà P; Bosman LP; Gasperetti A; Mazzanti A; Gourraud JB; Davies B; Frederiksen TC; Weidmann ZM; Di Marco A; Roberts JD; MacIntyre C; Seifer C; Delinière A; Alqarawi W; Kukavica D; Minois D; Trancuccio A; Arnaud M; Targetti M; Martino A; Oliviero G; Pipilas DC; Carbucicchio C; Compagnucci P; Dello Russo A; Olivotto I; Calò L; Lubitz SA; Cutler MJ; Chevalier P; Arbelo E; Priori SG; Healey JS; Calkins H; Casella M; Jensen HK; Tondo C; Tadros R; James CA; Krahn AD; Cadrin-Tourigny J
    Eur Heart J; 2022 Aug; 43(32):3041-3052. PubMed ID: 35766180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arrhythmogenic right ventricular cardiomyopathy: a focused update on diagnosis and risk stratification.
    Bosman LP; Te Riele ASJM
    Heart; 2022 Jan; 108(2):90-97. PubMed ID: 33990412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of arrhythmogenic right ventricular cardiomyopathy patients with an implantable cardioverter-defibrillator for prevention of sudden cardiac death.
    Yin K; Ding L; Li Y; Hua W
    Clin Cardiol; 2017 Apr; 40(4):216-221. PubMed ID: 28139837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and state of the art on the electrophysiologic characteristics and catheter ablation of arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Chung FP; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chao TF; Liao JN; Chiou CW; Chen SA
    J Cardiol; 2015 Jun; 65(6):441-50. PubMed ID: 25818480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical diagnosis and management strategies in arrhythmogenic right ventricular cardiomyopathy.
    Corrado D; Buja G; Basso C; Thiene G
    J Electrocardiol; 2000; 33 Suppl():49-55. PubMed ID: 11265736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arrhythmogenic right ventricular cardiomyopathy: current diagnostic and management strategies.
    Corrado D; Basso C; Nava A; Thiene G
    Cardiol Rev; 2001; 9(5):259-65. PubMed ID: 11520449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD?
    Wichter T; Paul TM; Eckardt L; Gerdes P; Kirchhof P; Böcker D; Breithardt G
    Herz; 2005 Mar; 30(2):91-101. PubMed ID: 15875097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk stratification for sudden death in arrhythmogenic right ventricular cardiomyopathy.
    Cadrin-Tourigny J; Tadros R; Talajic M; Rivard L; Abadir S; Khairy P
    Expert Rev Cardiovasc Ther; 2015 Jun; 13(6):653-64. PubMed ID: 25947965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy.
    Gasperetti A; James CA; Carrick RT; Protonotarios A; Te Riele ASJM; Cadrin-Tourigny J; Compagnucci P; Duru F; van Tintelen P; Elliot PM; Calkins H
    Europace; 2023 Nov; 25(11):. PubMed ID: 37935403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.
    Li CH; Lin YJ; Huang JL; Wu TJ; Cheng CC; Lin WS; Tuan TC; Chang SL; Lo LW; Hu YF; Chao TF; Chung FP; Tsai CF; Tsao HM; Chen SA
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):750-6. PubMed ID: 22353378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk.
    Mazzanti A; Ng K; Faragli A; Maragna R; Chiodaroli E; Orphanou N; Monteforte N; Memmi M; Gambelli P; Novelli V; Bloise R; Catalano O; Moro G; Tibollo V; Morini M; Bellazzi R; Napolitano C; Bagnardi V; Priori SG
    J Am Coll Cardiol; 2016 Dec; 68(23):2540-2550. PubMed ID: 27931611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arrhythmogenic Right Ventricular Cardiomyopathy: Risk Stratification and Indications for Defibrillator Therapy.
    Zorzi A; Rigato I; Bauce B; Pilichou K; Basso C; Thiene G; Iliceto S; Corrado D
    Curr Cardiol Rep; 2016 Jun; 18(6):57. PubMed ID: 27147509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arrhythmogenic right ventricular cardiomyopathy (ARVC): cardiovascular magnetic resonance update.
    te Riele AS; Tandri H; Bluemke DA
    J Cardiovasc Magn Reson; 2014 Jul; 16(1):50. PubMed ID: 25191878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic expression is a prerequisite for malignant arrhythmic events and sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy.
    Zorzi A; Rigato I; Pilichou K; Perazzolo Marra M; Migliore F; Mazzotti E; Gregori D; Thiene G; Daliento L; Iliceto S; Rampazzo A; Basso C; Bauce B; Corrado D
    Europace; 2016 Jul; 18(7):1086-94. PubMed ID: 26138720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.